We initiate coverage on Axon with a Sell rating and $608 PT, citing valuation risk despite robust growth and execution. Axon’s premium multiple is vulnerable to structural macro headwinds—high real ...
6don MSN
KeyBanc Adjusts Rubrik (RBRK) PT to $95 Citing Valuation Multiples and Enterprise Spending Caution
Rubrik Inc. (NYSE:RBRK) is one of the overlooked growth stocks to buy. On January 12, KeyBanc analyst Eric Heath lowered the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results